Agreement signedPublished 5 Jun 2023

Astellas /
Iveric

Astellas to acquire IVERIC bio for cash consideration

Price per share
$40.00/share
Stage
Agreement signed
Buy side: Astellas
Buy sideAstellas
Target: Iveric
TargetIveric
Source · 5 Jun 2023
Buy side: Astellas
Buy sideAstellas
Target: Iveric
TargetIveric
01 / BuyerAstellas
02 / TargetIveric
01

What happened

Astellas agreed to pay $40.00 per share in cash for IVERIC bio, Inc. The merger agreement provides that IVERIC will become a wholly owned subsidiary of Parent.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Astellas to acquire IVERIC bio for cash consideration

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.